|
|
||||||||
Institute of Immunology, Medical University of Vienna, Vienna, Austria
Dendritic cells (DC) are unique in their capacity to either stimulate or regulate T cells, and receptor/ligand pairs on DC and T cells are critically involved in this process. In this study we present such a molecule, which was discovered by us when analyzing the functional effects of an anti-DC mAb. This mAb, 11C9, reacted strongly with DC, but only minimally with lymphocytes. In MLR it constantly reduced DC-induced T cell activation. Therefore, we assumed that mAb 11C9 primarily exerts its functions by binding to a DC-structure. This does not seem to be the case, however. Preincubation of DC with mAb 11C9 before adding T cells had no inhibitory effect on T cell responses. Retroviral expression cloning identified the 11C9 Ag as CD63. This lysosomal-associated membrane protein (LAMP-3), is only minimally expressed on resting T cells but can, as we show, quickly shift to the surface upon stimulation. Cross-linkage of that structure together with TCR-triggering induces strong T cell activation. CD63 on T cells thus represents an alternative target for mAb 11C9 with its binding to activated T cells rather than DC being responsible for the observed functional effects. This efficient CD63-mediated costimulation of T cells is characterized by pronounced induction of proliferation, strong IL-2 production and compared with CD28 enhanced T cell responsiveness to restimulation. Particularly in this latter quality CD63 clearly surpasses several other CD28-independent costimulatory pathways previously described. CD63 thus represents an activation-induced reinforcing element, whose triggering promotes sustained and efficient T cell activation and expansion.
Related articles in The JI:
This article has been cited by other articles:
![]() |
K. Pfistershammer, A. Lawitschka, C. Klauser, J. Leitner, R. Weigl, M. H. M. Heemskerk, W. F. Pickl, O. Majdic, G. A. Bohmig, G. F. Fischer, et al. Allogeneic disparities in immunoglobulin-like transcript 5 induce potent antibody responses in hematopoietic stem cell transplant recipients Blood, September 10, 2009; 114(11): 2323 - 2332. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Schroder, R. Lullmann-Rauch, N. Himmerkus, I. Pleines, B. Nieswandt, Z. Orinska, F. Koch-Nolte, B. Schroder, M. Bleich, and P. Saftig Deficiency of the Tetraspanin CD63 Associated with Kidney Pathology but Normal Lysosomal Function Mol. Cell. Biol., February 15, 2009; 29(4): 1083 - 1094. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Ruiz-Mateos, A. Pelchen-Matthews, M. Deneka, and M. Marsh CD63 Is Not Required for Production of Infectious Human Immunodeficiency Virus Type 1 in Human Macrophages J. Virol., May 15, 2008; 82(10): 4751 - 4761. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Pfistershammer, C. Klauser, J. Leitner, J. Stockl, O. Majdic, T. Weichhart, Y. Sobanov, V. Bochkov, M. Saemann, G. Zlabinger, et al. Identification of the scavenger receptors SREC-I, Cla-1 (SR-BI), and SR-AI as cellular receptors for Tamm-Horsfall protein J. Leukoc. Biol., January 1, 2008; 83(1): 131 - 138. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Wu, T. Baumgart, S. Hammond, D. Holowka, and B. Baird Differential targeting of secretory lysosomes and recycling endosomes in mast cells revealed by patterned antigen arrays J. Cell Sci., September 1, 2007; 120(17): 3147 - 3154. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |